Oesophageal surgery.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 11854896)

Published in World J Gastroenterol on December 01, 2001

Authors

E J Simchuk1, D Alderson

Author Affiliations

1: University Department of Surgery, Bristol Royal Infirmary, Bristol BS2 8HW, UK.

Articles cited by this

Reflux esophagitis, sliding hiatal hernia, and the anatomy of repair. Surg Gynecol Obstet (1951) 11.05

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med (1996) 9.85

Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg (1980) 5.76

Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients. J Thorac Cardiovasc Surg (1967) 4.67

Nissen fundoplication for gastroesophageal reflux disease. Evaluation of primary repair in 100 consecutive patients. Ann Surg (1986) 4.22

Surgical therapy of oesophageal carcinoma. Br J Surg (1990) 3.94

Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis (1976) 3.71

Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology (1996) 3.70

Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut (1989) 3.60

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56

Laparoscopic Nissen fundoplication: preliminary report. Surg Laparosc Endosc (1991) 3.27

Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology (1986) 3.16

Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09

An effective operation for hiatal hernia: an eight year appraisal. Ann Surg (1967) 3.07

[A simple operation for control of reflux esophagitis]. Schweiz Med Wochenschr (1956) 2.78

Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg (2000) 2.53

A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer (1994) 2.17

Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg (1996) 2.11

Gastroesophageal reflux disease. JAMA (1996) 2.09

Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol (1993) 2.05

Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg (1979) 1.92

Total three-stage oesophagectomy for cancer of the oesophagus. Br J Surg (1976) 1.79

Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system. Gastroenterology (1989) 1.70

A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg (1997) 1.68

The surgical treatment of carcinoma of the oesophagus; with special reference to a new operation for growths of the middle third. Br J Surg (1946) 1.65

Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet (1991) 1.64

Potentially curable cancer of the esophagus. Cancer (1982) 1.53

High amplitude, peristaltic esophageal contractions associated with chest pain and/or dysphagia. Gastroenterology (1979) 1.51

Thoracoscopic staging of esophageal cancer: a prospective, multiinstitutional trial. Cancer and Leukemia Group B Thoracic Surgeons. Ann Thorac Surg (1995) 1.51

Esophageal resection for cancer: the rationale of current practice. Am J Surg (1987) 1.36

New technology for the division of short gastric vessels during laparoscopic Nissen fundoplication. A prospective randomized trial. Surg Endosc (1996) 1.34

Relationship of a hiatal hernia to the function of the body of the esophagus and the gastroesophageal junction. J Thorac Cardiovasc Surg (1981) 1.34

Oesophagomyotomy for achalasia: a 22-year experience. Br J Surg (1993) 1.30

Systematic use of gastric fundoplication in laparoscopic repair of paraesophageal hernias. Am J Surg (1996) 1.29

Repair of paraesophageal hernias. Am J Surg (1999) 1.25

Changing strategies in the performance of laparoscopic Nissen fundoplication as a result of experience with 230 operations. Surg Endosc (1995) 1.22

Gastroesophageal sphincter pressure and histological changes in distal esophagus in patients with achalasia of the esophagus. Dig Dis Sci (1985) 1.22

Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg (1999) 1.21

Successful laparoscopic repair of paraesophageal hernia. Arch Surg (1995) 1.18

Achalasia of the esophagus: results of therapy by dilation, 1950-1967. Chest (1970) 1.18

Cervical or thoracic anastomosis for esophagectomy for carcinoma. Surg Gynecol Obstet (1989) 1.16

Evaluation of endosonography in TN staging of oesophageal cancer. Gut (1991) 1.10

Laparoscopic repair of paraesophageal hernia. New access, old technique. Surg Endosc (1995) 1.09

Circadian esophageal motor function in patients with gastroesophageal reflux disease. Surgery (1990) 1.06

Heller myotomy via minimal-access surgery. An evaluation of antireflux procedures. Arch Surg (1996) 1.02

Ten to 20-year clinical results after short esophagomyotomy without an antireflux procedure (modified Heller operation) for esophageal achalasia. Eur J Cardiothorac Surg (1992) 0.99

Function of the intrathoracic stomach as esophageal replacement. World J Surg (1988) 0.97

Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut (1997) 0.95

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol (1998) 0.91

Results of the surgical treatment of carcinoma of the esophagus. Surg Gynecol Obstet (1983) 0.91

Long-term comparison of antireflux surgery versus conservative therapy for reflux esophagitis. Ann Surg (1997) 0.90

Minimally invasive approaches to achalasia. Semin Gastrointest Dis (1994) 0.89

Outpatient physiologic testing and surgical management of foregut motility disorders. Curr Probl Surg (1992) 0.88

Value of physiologic assessment of foregut symptoms in a surgical practice. Surgery (1993) 0.87

Transition from nutcracker esophagus to achalasia. Dig Dis Sci (1990) 0.85

Malignant pseudoachalasia. Surg Endosc (1999) 0.84

Physiologic assessment and surgical management of diffuse esophageal spasm. J Thorac Cardiovasc Surg (1992) 0.84

Esophageal perforations after forceful dilatation in achalasia. Ann Surg (1982) 0.81

Long-term outcomes following esophagectomy. Chest Surg Clin N Am (2000) 0.81

History of surgery of the esophagus. Am J Surg (1980) 0.80

Esophageal physiology and pathophysiology. Surg Clin North Am (1993) 0.78

Modification of the Hill technique for repair of hiatal hernia. Surg Gynecol Obstet (1976) 0.78

Fifteen- to twenty-year results after the Hill antireflux operation. J Thorac Cardiovasc Surg (1989) 0.77

[Contribution of endosonography to preoperative staging in esophageal and stomach cancer]. Chirurg (1989) 0.76

[The significance of the extensive systematic lymphadenectomy for thoracic esophageal carcinoma]. Nihon Geka Gakkai Zasshi (1989) 0.76

Belsey Mark IV antireflux procedure. Chest Surg Clin N Am (1995) 0.76

Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus. Chest (1998) 0.76

Articles by these authors

A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer (2000) 1.71

Endoscopic ultrasonography in the evaluation of idiopathic acute pancreatitis. Br J Surg (2000) 1.60

Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer (2001) 1.58

Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer (2003) 1.56

Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Ann Oncol (1995) 1.53

Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers. Br J Surg (2002) 1.43

Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer (2003) 1.33

Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut (2011) 1.29

Quality of life measurement in patients with oesophageal cancer. Gut (1995) 1.21

Fifteen-year review of the mortality of brain abscess. Neurosurgery (1981) 1.17

Systematic review of intraperitoneal chemotherapy for gastric cancer. Br J Surg (2011) 1.15

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. Br J Pharmacol (2013) 1.09

The sphinctometer: a new device for measurement of lower oesophageal sphincter function. Br J Surg (1991) 1.09

Peritoneal lavage cytology in patients with oesophagogastric adenocarcinoma. Br J Surg (2008) 1.06

Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease. Gut (1995) 1.05

Pressure events surrounding oesophageal acid reflux episodes and acid clearance in ambulant healthy volunteers. Gut (1993) 1.05

Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer (1996) 1.05

The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut (2001) 1.04

Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg (2007) 1.04

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. Eur J Surg Oncol (1997) 1.04

Prospective comparison of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the detection of bile duct stones. Br J Surg (1997) 1.01

Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg (1995) 1.01

Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut (1994) 0.99

Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg (2008) 0.96

A technique for raising tragal perichondrium. Clin Otolaryngol (2010) 0.96

Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry. Gut (1997) 0.95

Primary yolk sac tumour of the liver in adulthood. J Clin Pathol (1998) 0.94

Health-related quality of life and survival in the 2 years after surgery for gastric cancer. Eur J Surg Oncol (2010) 0.94

IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. Int J Cancer (2000) 0.93

Assessment of satisfaction with care after inpatient treatment for oesophageal and gastric cancer. Br J Surg (2004) 0.93

The role of preoperative TIPSS to facilitate curative gastric surgery. Cardiovasc Intervent Radiol (2003) 0.93

Influence of specialization on the management and outcome of patients with pancreatic cancer. Br J Surg (2003) 0.92

Isolation and quantification of canine islet tissue for transplantation. Transplantation (1987) 0.91

Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer (2003) 0.89

Oesophageal cancer staging using endoscopic ultrasonography. Br J Surg (1998) 0.88

Comparison of harvesting methods for islet transplantation. Br J Surg (1986) 0.88

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus. J Clin Pathol (1995) 0.87

Evidence implicating a mid-region sequence of IGFBP-3 in its specific IGF-independent actions. J Cell Biochem (2002) 0.86

Influence of luminal obstruction on oesophageal cancer staging using endoscopic ultrasonography. Br J Surg (1998) 0.86

Oesophageal acid clearance in patients with severe reflux oesophagitis. Br J Surg (1995) 0.85

Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. Br J Surg (2005) 0.84

Expanding metal stents in the gastrointestinal tract. Br J Surg (1995) 0.84

Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. J Clin Pathol (2004) 0.84

Quality of life in patients with oesophageal cancer. Recent Results Cancer Res (2000) 0.83

Long-term cryogenic storage of purified adult human islets of Langerhans. Diabetes (1989) 0.83

Ambulatory measurement of oesophageal function: clinical use of a new pH and motility recording system. Br J Surg (1992) 0.82

Human papillomavirus and oesophageal squamous cell carcinoma in the UK. Eur J Surg Oncol (1997) 0.82

Plasminogen activators in oesophageal carcinoma. Br J Surg (1996) 0.81

Brush cytology in the diagnosis of neoplasia in Barrett's esophagus. Dis Esophagus (1997) 0.81

Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs. Gut (1989) 0.81

Endoscopic sphincterotomy before pancreaticoduodenectomy for ampullary carcinoma. Br Med J (Clin Res Ed) (1981) 0.81

Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma. Eur J Surg Oncol (1999) 0.81

A prospective study of patient reported outcomes in pancreatic and peri-ampullary malignancy. World J Surg (2013) 0.80

The isolation and purification of human pancreatic islets. Transplant Proc (1987) 0.80

Patient selection and timing of dynamic computed tomography in acute pancreatitis. Br J Surg (1993) 0.80

Islet cell transplantation in diabetic dogs: studies of graft function and storage. Br J Surg (1984) 0.80

Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer (Br J Surg 2001; 88: 1617-22). Br J Surg (2002) 0.78

Diet, reflux and the development of squamous cell carcinoma of the oesophagus in Africa. Br J Surg (1998) 0.77

Investigation of oesophageal adenocarcinoma for viral genomic sequences. Eur J Surg Oncol (1997) 0.77

Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma. Eur J Surg Oncol (1998) 0.77

Diurnal insulin and glucose profiles following transplantation of fresh and cryopreserved canine pancreatic islets. Br J Surg (1989) 0.76

Long-term normoglycemia in pancreatectomized dogs following pancreatic islet allotransplantation and cyclosporine immunosuppression. Transplantation (1987) 0.76

Prolonged cryopreservation of purified human pancreatic islets. Diabetes (1989) 0.76

Islet autotransplantation in the pancreatectomized dog: effect of time on graft function. World J Surg (1984) 0.76

Cyclosporine A immunosuppression of allotransplanted canine pancreatic islets. Transplant Proc (1987) 0.76

Diffuse esophageal spasm. Dig Dis Sci (1992) 0.75

Getting the best quality: use the right instrument. J R Soc Med (1995) 0.75

Neoadjuvant chemotherapy in operable adenocarcinoma of the oesophagus. Clin Oncol (R Coll Radiol) (2001) 0.75

An update in the palliative management of malignant dysphagia. Eur J Surg Oncol (2001) 0.75

Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia (Br J Surg 2003; 90: 1120-1128). Br J Surg (2003) 0.75

Gas and liquid reflux during transient lower oesophageal sphincter relaxation. Gut (1999) 0.75

Failure of canine islet allotransplantation after kidney transplantation. Diabetes (1989) 0.75

Successful autotransplantation of cryopreserved dispersed pancreatic grafts in dogs. Transplantation (1984) 0.75

Review: chemotherapy, irradiation and their roles in the management of oesophageal cancer. J Gastroenterol Hepatol (1997) 0.75

Nothing new under the sun: the management of epistaxis. J Laryngol Otol (1998) 0.75

Dispersed pancreatic graft cryopreservation in the dog: in vivo assessment of preservation protocols. Cryobiology (1987) 0.75

The metabolic effects of islet transplantation in the diabetic dog. Transplant Proc (1984) 0.75

A century at the cutting edge. Br J Surg (2013) 0.75

The effects of immunosuppression on islet transplant function in the dog. Transplant Proc (1987) 0.75

Metabolic comparison between canine islet autografts with portal and peripheral venous drainage. Transplant Proc (1987) 0.75

Scottish Intercollegiate Guidelines Network (SIGN) 87--the management of oesophageal and gastric cancer. Clin Oncol (R Coll Radiol) (2008) 0.75

Should we continue oesophageal surgery in a district general hospital? A review of 200 consecutive cases. Ann R Coll Surg Engl (2002) 0.75

Prior renal transplantation does not facilitate subsequent canine islet allograft survival. Br J Surg (1989) 0.75

The place of research in surgical training. Br J Hosp Med (1995) 0.75

Nutritional support in patients with malignant strictures of the oesophagus using a fine-bore feeding tube. Hum Nutr Clin Nutr (1983) 0.75

Tracheal paraganglioma: a diagnostic dilemma culminating in a complex airway management problem. J Laryngol Otol (2001) 0.75

Long-term mass storage of purified human pancreatic islets. Transplant Proc (1988) 0.75

Use of intravenous normal immunoglobulin in high doses as a possible safer alternative to oral steroids in managing HIV-associated immune thrombocytopenic purpura. J Infect (1986) 0.75

The effects of transplant mass on insulin release by collagenase-dispersed pancreatic fragments in the diabetic dog. World J Surg (1984) 0.75

Demonstration of pancreatic parenchyma by digital subtraction techniques during endoscopic retrograde cholangiopancreatography. Clin Radiol (1985) 0.75